CD274 and neoplasm: Tumor cells can suppress Tcell function and reduce immunotherapy efficacy by upregulating PD-L1 expression and enhancing the immunosuppressive microenvironment, such as the accumulation of myeloid-derived suppressor cells and tumor-associated macrophages.